Pernod Ricard stock weighs India IPO plans against US, China weakness

Pernod Ricard reported a sharply divided start to fiscal 2027 on October 15, with strong Indian demand partly offsetting weakness in the United States and China. In its Q1 FY27 sales release, the spirits group said organic net sales fell 0.9 percent to 2.234 billion euros. Reported sales declined 6.3 percent, partly reflecting portfolio changes and foreign-exchange effects.

Pernod Ricard stock traded at 72.04 euros on Lang & Schwarz at 12:08 CET on Friday, November 13, 2026, 0.36 percent above the Xetra close of Thursday, November 12, at 71.78 euros. The quote places the focus on whether strong growth in India can offset continued pressure in the group's largest developed markets.

India remains the growth engine

India was the strongest major growth market in the quarter, with sales increasing 19 percent. Pernod Ricard attributed the performance to strong consumer demand and continuing premiumisation. Growth was broad-based across imported and local brands, including Jameson, Absolut, Ballantine's, Royal Stag and Blenders Pride.

The company is taking preparatory steps for a potential initial public offering of its Indian business. Pernod Ricard said the preparations created a favourable pipe-fill effect that further supported first-quarter sales. Any decision to proceed remains subject to board approval, so the plan has not yet become a confirmed transaction.

US and China remain the drag

The regional contrast was most visible in the United States and China. US sales declined 10 percent, while China sales fell 25 percent. Inventory adjustments affected both markets, keeping the recovery uneven despite signs of improvement in China.

Pernod Ricard said underlying depletions in China returned to growth ahead of the Mid-Autumn Festival. The company nevertheless expects inventory effects and weak conditions in the US and China to continue weighing on the current financial year. Outside those two markets, sales increased 4 percent, while group volumes returned to growth at 6 percent.

Stable outlook leaves execution in focus

Management expects organic net sales to remain broadly stable in FY27. The outlook assumes further declines in the US and China, partly offset by continued momentum in the rest of the world, particularly India.

For FY27 to FY29, Pernod Ricard expects average organic sales growth near the lower end of its 3 percent to 6 percent range. The group also plans strategic investments of about 700 million euros and targets cash conversion of about 90 percent. It aims to keep net debt to EBITDA below three times by FY29 while defending operating margin through cost control and efficiency measures.

For investors, the key issue is the timing of a recovery in the US and China. India's growth provides a clear counterweight, but the regional imbalance leaves the shares dependent on sustained momentum in emerging markets and signs that inventory reductions are easing in the two pressured markets.

The Euro Stoxx 50 remains a relevant market benchmark for investors monitoring large European consumer companies.

Further updates for investors are expected around Pernod Ricard's Annual General Meeting on November 20. More news and analyses on Pernod Ricard stock.